Clinical Trial Update: Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating SAR339658 for moderate to severe ulcerative colitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SAR339658

Snippet

Sponsor: Sanofi | Conditions: Ulcerative Colitis | Phase 2 | Status: TERMINATED